28 related articles for article (PubMed ID: 17454776)
1. Guidelines for the first line management of classical Hodgkin lymphoma.
Follows GA; Ardeshna KM; Barrington SF; Culligan DJ; Hoskin PJ; Linch D; Sadullah S; Williams MV; Wimperis JZ;
Br J Haematol; 2014 Jul; 166(1):34-49. PubMed ID: 24712411
[No Abstract] [Full Text] [Related]
2. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.
Menzel L; Höpken UE; Rehm A
Front Immunol; 2020; 11():591741. PubMed ID: 33343570
[TBL] [Abstract][Full Text] [Related]
3. Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma.
Agrusa JE; Scull BP; Abhyankar HA; Lin H; Ozuah NW; Chakraborty R; Eckstein OS; Gulati N; Fattah EA; El-Mallawany NK; Rouce RH; Dreyer ZE; Brackett J; Margolin JF; Lubega J; Horton TM; Bollard CM; Gramatges MM; Kamdar KY; McClain KL; Man TK; Allen CE
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33276546
[TBL] [Abstract][Full Text] [Related]
4. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
Nagpal P; Descalzi-Montoya DB; Lodhi N
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.
Nagpal P; Akl MR; Ayoub NM; Tomiyama T; Cousins T; Tai B; Carroll N; Nyrenda T; Bhattacharyya P; Harris MB; Goy A; Pecora A; Suh KS
Oncotarget; 2016 Oct; 7(41):67551-67573. PubMed ID: 27563824
[TBL] [Abstract][Full Text] [Related]
6. Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment.
Shafat I; Barak AB; Postovsky S; Elhasid R; Ilan N; Vlodavsky I; Arush MW
Neoplasia; 2007 Nov; 9(11):909-16. PubMed ID: 18030359
[TBL] [Abstract][Full Text] [Related]
7. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
8. [Primary multifocal osseous Hodgkin lymphoma].
Oshikawa G; Arai A; Sasaki K; Ichinohasama R; Miura O
Rinsho Ketsueki; 2009 Feb; 50(2):92-6. PubMed ID: 19265301
[TBL] [Abstract][Full Text] [Related]
9. Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.
Ben Arush MW; Shafat I; Ben Barak A; Shalom RB; Vlodavsky I; Ilan N
Pediatr Hematol Oncol; 2009 Jun; 26(4):157-64. PubMed ID: 19437318
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
11. Serum vascular endothelial growth factor as a significant marker of treatment response in pediatric malignancies.
Ben Arush MW; Schenzer P; Maurice S; Elhasid R; Postovsky S; Ben Barak A; Haimi M; Zeidman I; Hayari L; Livne E
Pediatr Hematol Oncol; 2005 Sep; 22(6):513-24. PubMed ID: 16169818
[TBL] [Abstract][Full Text] [Related]
12. [Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma].
Kobayashi K; Yokote T; Akioka T; Hara S; Oka S; Hiraoka N; Hirata Y; Miyoshi T; Tsuji M; Hanafusa T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1327-30. PubMed ID: 17687225
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
14. Serum VEGF as a significant marker of treatment response in hodgkin lymphoma.
Ben Arush MW; Ben Barak A; Maurice S; Livne E
Pediatr Hematol Oncol; 2007 Mar; 24(2):111-5. PubMed ID: 17454776
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
